Accelevation (NASDAQ:ACCV) Stock Rated Equal Weight in New Coverage at Morgan Stanley

Key Points

• Morgan Stanley initiated coverage of Accelevation with an “equal weight” rating and an $18 price target, implying 45.4% potential upside from the stock’s $12.38 price.
• Analyst sentiment is broadly positive: seven analysts rate ACCV a Buy and one rates it Hold, producing a consensus “Moderate Buy” rating and an average price target of $19.33.
• Insiders have been buying shares, including purchases by the COO and a director at $18 per share; insiders acquired 227,700 shares worth approximately $4.1 million over the past three months.

Equities researchers at Morgan Stanley started coverage on shares of Accelevation (NASDAQ:ACCV - Get Free Report) in a research report issued to clients and investors on Monday, Marketbeat.com reports. The brokerage set an "equal weight" rating and a $18.00 price target on the stock. Morgan Stanley's target price points to a potential upside of 45.40% from the stock's current price.

ACCV has been the topic of several other research reports. The Goldman Sachs Group started coverage on Accelevation in a report on Monday. They set a "buy" rating and a $22.00 target price on the stock. Bank of America started coverage on shares of Accelevation in a research note on Monday. They set a "buy" rating and a $20.00 price objective on the stock. JPMorgan Chase & Co. started coverage on Accelevation in a report on Monday. They issued an "overweight" rating and a $20.00 price target for the company. Barclays started coverage on shares of Accelevation in a research report on Monday. They issued an "overweight" rating and a $20.00 price objective on the stock. Finally, Wall Street Zen raised shares of Accelevation to a "hold" rating in a research report on Saturday, October 10th. Seven equities research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average price target of $19.33.

Accelevation Price Performance

ACCV opened at $12.38 on Monday. Accelevation has a 1 year low of $11.58 and a 1 year high of $18.10.

Insiders Place Their Bets

In other Accelevation news, COO Brent Jewell bought 2,500 shares of Accelevation stock in a transaction on Thursday, October 1st. The shares were purchased at an average price of $18.00 per share, with a total value of $45,000.00. Following the acquisition, the chief operating officer owned 304,068 shares in the company, valued at $5,473,224. This trade represents a 0.83% increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Howard Heckes acquired 5,000 shares of Accelevation stock in a transaction that occurred on Thursday, October 1st. The stock was acquired at an average cost of $18.00 per share, for a total transaction of $90,000.00. Following the completion of the purchase, the director directly owned 5,000 shares of the company's stock, valued at $90,000. This represents a ∞ increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Insiders purchased a total of 227,700 shares of company stock valued at $4,098,600 over the last three months.

About Accelevation

Accelevation Corporation NASDAQ: ACCV is a special purpose acquisition company (SPAC) formed to identify and combine with an operating business through a merger, share exchange, asset acquisition, reorganization or similar transaction.

Unlike an operating company, Accelevation does not manufacture products, provide ongoing commercial services or conduct significant business activities of its own. Its primary activities have consisted of evaluating potential acquisition targets and pursuing a business combination.

Public information about Accelevation's operating history, geographic footprint and leadership is limited.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.